法国民众新冠疫苗接种意愿与临床试验参与意愿调查
年龄较大、男性、对新冠恐惧、医护人员及感知风险较高与接种接受度相关,疫苗犹豫是接种和试验参与的主要障碍。
要点
- 77.6%受访者表示愿意接种新冠疫苗,47.6%愿意参与疫苗临床试验。
- 年龄较大、男性、医护人员及感知风险高者接种意愿更高。
- 疫苗犹豫与接种接受度降低及拒绝参与临床试验相关。
核心结论
- 近75%受访者可能接受新冠疫苗接种,约48%可能参与新冠疫苗临床试验。
- 疫苗犹豫将是新冠疫苗接种的主要障碍。
主要发现
- 年龄较大、男性、对COVID-19恐惧、医护人员及个体感知风险与新冠疫苗接受度相关。
- 疫苗犹豫与新冠疫苗接受度降低及拒绝参与临床试验相关。
临床怎么用
- 针对疫苗犹豫人群开展沟通干预可能提升新冠疫苗接种意愿。
- 招募临床试验参与者时可关注高意愿人群特征以提高效率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The world is facing the COVID-19 pandemic. The development of a vaccine is challenging. We aimed to determine the proportion of people who intend to get vaccinated against COVID-19 in France or to participate in a vaccine clinical trial. METHODS: We conducted an anonymous on-line survey from the 26th of March to the 20th of April 2020. Primary endpoints were the intention to get vaccinated against COVID-19 if a vaccine was available or participate in a vaccine clinical trial. RESULTS: Three thousand two hundred and fifty nine individuals answered the survey; women accounted for 67.4% of the respondents. According to their statements, 2.512 participants (77.6%, 95% CI 76.2-79%) will certainly or probably agree to get vaccinated against COVID-19. Older age, male gender, fear about COVID-19, being a healthcare worker and individual perceived risk were associated with COVID-19 vaccine acceptance. Vaccine hesitancy was associated with a decrease in COVID-19 vaccine acceptance. One thousand and five hundred and fifty respondents (47.6% 95% CI 45.9-49.3%) will certainly or probably agree to participate in a COVID-19 vaccine clinical trial. Older age, male gender, being a healthcare worker and individual perceived risk were associated with potential acceptance to participate in a COVID-19 vaccine clinical trial. Vaccine hesitancy was associated with refusal for participation in a COVID-19 vaccine clinical trial. CONCLUSIONS: Nearly 75% and 48% of the survey respondents were respectively likely to accept vaccination or participation in a clinical trial against COVID-19. Vaccine hesitancy will be the major barrier to COVID-19 vaccine uptake.
引用
- Detoc M, Bruel S, Frappe P, et al. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020. PMID: 32988688. doi:10.1016/j.vaccine.2020.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。